Cannell Capital LLC Angion Biomedica Corp. Transaction History

Cannell Capital LLC

  • $422 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.94 - $1.23 $32,027 - $41,908
34,072 Added 557.73%
40,181 $37,000
Q2 2022

Aug 15, 2022
BUY
$1.1 - $2.23 $6,719 - $13,623
6,109 New
6,109 $7,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Cannell Capital LLC Portfolio

Follow Cannell Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannell Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email